New Food and Drug Administration–Approved and Emerging Novel Treatment Options for Acute Myeloid Leukemia
Year: 2018
Type: review
DOI: 10.1002/phar.2180
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890607923
